Illumina Respiratory Virus Enrichment Kit

Highly sensitive detection and characterization of common respiratory viruses, including SARS-CoV-2 strains, with comprehensive, rapid target enrichment sequencing. Read More...
Select Product(s)
Which products do I need?

Illlumina Respiratory Virus Enrichment Kit Set A (96 indexes, 96 samples)

20100469

Price
 
 

Illumina Respiratory Virus Enrichment Kit Set B (96 indexes, 96 samples)

20100470

Price
 
 

Illumina Respiratory Virus Enrichment Kit Set C (96 indexes, 96 samples)

20100471

Price
 
 

Illumina Respiratory Virus Enrichment Kit Set D (96 indexes, 96 samples)

20100472

Price
 
 

Product Highlights

The Illumina Respiratory Virus Enrichment Kit allows researchers to obtain whole-genome next-generation sequencing (NGS) data for over 40 important respiratory viruses including SARS-CoV-2 and influenza A/B viruses. This kit enables the identification of targeted viruses present, identification and tracking of variants, and viral surveillance on a wide array of sample types.1

Target Enrichment for Respiratory Virus Detection

Target enrichment through hybrid–capture methods allows for highly sensitive detection without requiring the high read depth necessary with shotgun metagenomic sequencing. Additionally, this method allows for near-complete whole-genome sequence data acquisition of viral targets and provides flexible solutions for a wide variety of different applications. Compared to other targeted resequencing methods, such as amplicon sequencing, enrichment-based hybrid capture allows for dramatically larger probe panels with a more comprehensive profiling of many different viral targets in a single experiment. Additionally, oligo probes used for hybrid–capture remain effective even within highly mutagenic regions, allowing for the targeting of rapidly evolving viruses, such as influenza viruses and other RNA viruses.

Streamlined Workflow

This comprehensive workflow integrates library preparation, target enrichment, sequencing, and data analysis. The workflow is intended to enrich viral targets from extracted total nucleic acid since both RNA and DNA viruses are targeted with this enrichment panel.

Reverse transcription of extracted RNA, library preparation, and enrichment are performed using the well-established, robust Illumina RNA Prep with Enrichment reagents and protocol in conjunction with the Respiratory Virus Oligo Panel v2 provided within the kit. After sequencing on an Illumina NGS system, data analysis can be performed using the DRAGEN RNA Pathogen Detection App on the BaseSpace Sequence Hub.

  1. Gaudin M and Desnues C. Hybrid Capture-Based Next Generation Sequencing and Its Application to Human Infectious Diseases. Front Microbiol. 2018; 9:2924.

Frequently Purchased Together

Specifications

Product Comparison

Illumina Respiratory Virus Enrichment Kit Respiratory Pathogen ID/AMR Enrichment Panel Kit
Assay Time < 9 hours library prep time < 9 hours library prep time
Automation Capability Liquid Handling Robots Liquid Handling Robots
Description A streamlined workflow for detecting and analyzing SARS-CoV-2 and other common respiratory viruses using Illumina RNA Prep with Enrichment reagents combined with the Respiratory Virus Oligo Panel v2 for library prep and enrichment, Illumina sequencing, and simplified data analysis using the DRAGEN Microbial Enrichment App. A streamlined workflow using Respiratory Pathogen ID/AMR Panel (RPIP) with Illumina RNA Prep with Enrichment, sequencing on Illumina desktop systems, and powerful analysis using Explify RPIP Software allows researchers to identify respiratory infections and co-infections, identify antimicrobial resistance, and perform strain typing of critical pathogens (SARS-CoV-2 and Flu A/B viruses) to study viral evolution and transmission.
Hands-On Time < 2 hours library prep and enrichment time < 2 hours library prep and enrichment time
Input Quantity 10-100 ng 10-100 ng
Multiplexing Up to 384 samples in a single run with unique dual indexes Up to 384 samples in a single run with unique dual indexes
Species Category Human, Virus Bacteria, Fungal, Virus
Species Details Detects common respiratory viruses, including recent influenza virus strains and SARS-CoV-2. The panel includes probes to human targets as a quality feature, and therefore detects those human targets in every sample assayed. Detects respiratory pathogens (180+ bacteria, 50+ fungi, and 40+ viruses, including SARS-CoV-2) and antimicrobial resistance alleles (1200+).
System Compatibility MiniSeq, MiSeq, NextSeq 1000, NextSeq 2000, NextSeq 550 MiniSeq, MiSeq, NextSeq 550

Example Workflow

 

Supporting Data and Figures

 

Related Products